A randomized controlled trial of a “Small Changes” behavioral weight loss treatment delivered in cardiac rehabilitation for patients with atrial fibrillation and obesity: study protocol for the BE-WEL in CR-AF study

Andrade JG, Aguilar M, Atzema C, Bell A, Cairns JA, Cheung CC, et al. The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation. Can J Cardiol. 2020;36(12):1847–948.

Article  PubMed  Google Scholar 

Shu H, Cheng J, Li N, Zhang Z, Nie J, Peng Y, Wang Y, Wang DW, Zhou N. Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance. Cardiovasc Diabetol. 2023;22(1):192.

Article  PubMed  PubMed Central  Google Scholar 

Lavie CJ, Pandey A, Lau DH, Alpert MA, Sanders P. Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise. J Am Coll Cardiol. 2017;70(16):2022–35.

Article  PubMed  Google Scholar 

Morin DP, Bernard ML, Madias C, Rogers PA, Thihalolipavan S, Estes NAM. The state of the art: atrial fibrillation epidemiology, prevention, and treatment. Vol. 91, Mayo Clinic Proceedings. Elsevier Ltd; 2016. p. 1778–810.

Wingerter R, Steiger N, Burrows A, Estes NM III. Impact of lifestyle modification on atrial fibrillation. Am J Cardiol. 2020;125(2):289–97.

Article  PubMed  Google Scholar 

Lau DH, Nattel S, Kalman JM, Sanders P. Modifiable risk factors and atrial fibrillation. Circulation. 2017;136(6):583–96.

Article  PubMed  Google Scholar 

Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt LL, Goldberger ZD, Gopinathannair R, Gorenek B. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e1–56.

Ganesan AN, Shipp NJ, Brooks AG, Kuklik P, Lau DH, Lim HS, Sullivan T, Roberts-Thomson KC, Sanders P. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2(2): e004549.

Article  PubMed  PubMed Central  Google Scholar 

Mujović N, Marinković M, Lenarczyk R, Tilz R, Potpara TS. Catheter ablation of atrial fibrillation: an overview for clinicians. Adv Ther. 2017;34:1897–917.

Article  PubMed  PubMed Central  Google Scholar 

Hindricks G, Potpara T, Kirchhof P, Kühne M, Ahlsson A, Balsam P, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Vol. 42, European Heart Journal. Oxford University Press; 2021. p. 373–498.

Wang TJ, Parise H, Levy D, D’Agostino RB, Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fibrillation. J Am Med Assoc. 2004;292(20):2471–7.

Article  CAS  Google Scholar 

Homan EA, Reyes M V., Hickey KT, Morrow JP. Clinical overview of obesity and diabetes mellitus as risk factors for atrial fibrillation and sudden cardiac death. Front Physiol. 2019;10(JAN).

Vasan RS, Magnani JW, Lubitz SA, McManus DD, Larson MG, Newton-Cheh C, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. The Lancet. 2015 Jul 11;386(9989):154–62. Available from: https://www-sciencedirect-com.ezproxy.lib.ucalgary.ca/science/article/pii/S0140673614617748. [cited 2018 Nov 26].

Wong CX, Abed HS, Molaee P, Nelson AJ, Brooks AG, Sharma G, Leong DP, Lau DH, Middeldorp ME, Roberts-Thomson KC, Wittert GA. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol. 2011;57(17):1745–51.

Article  PubMed  Google Scholar 

Sandhu RK, Conen D, Tedrow UB, Fitzgerald KC, Pradhan AD, Ridker PM, et al. Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation. J Am Heart Assoc. 2014 May 1;3(3):e000916. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24786144. [cited 2020 Jan 24].

Abed HS, Wittert GA, Leong DP, Shirazi MG, Bahrami B, Middeldorp ME, et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA - Journal of the American Medical Association. 2013;310(19):2050–60.

Article  PubMed  CAS  Google Scholar 

Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014;64(21):2222–31.

Article  PubMed  Google Scholar 

Aldaas OM, Lupercio F, Han FT, Hoffmayer KS, Krummen D, Ho G, et al. Meta-analysis of effect of modest (≥10%) weight loss in management of overweight and obese patients with atrial fibrillation. Am J Cardiol. 2019;124(10):1568–74.

Article  PubMed  PubMed Central  Google Scholar 

Stone JA, editor. Canadian guidelines for cardiac rehabilitation and cardiovascular disease prevention: translating knowledge into action. 3rd ed. Winnipeg, MB: Canadian Association of Cardiac Rehabilitation; 2009.

Balady GJ, Ades PA, Bittner VA, Franklin BA, Gordon NF, Thomas RJ, et al. Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the american heart association. Circulation. 2011;124(25):2951–60.

Article  PubMed  Google Scholar 

Taylor RS, Dalal HM, McDonagh STJ. The role of cardiac rehabilitation in improving cardiovascular outcomes. Vol. 19, Nature Reviews Cardiology. Nature Research; 2022. p. 180–94.

Oesterle A, Giancaterino S, Van Noord MG, Pellegrini CN, Fan D, Srivatsa UN, et al. effects of supervised exercise training on atrial fibrillation: a meta-analysis of randomized controlled trials. J Cardiopulm Rehabil Prev. 2022;42(4):258–65.

Article  PubMed  Google Scholar 

Smart NA, King N, Lambert JD, Pearson MJ, Campbell JL, Risom SS, et al. Exercise-based cardiac rehabilitation improves exercise capacity and health-related quality of life in people with atrial fibrillation: a systematic review and meta-analysis of randomised and non-randomised trials. Open Heart. 2018;5(2):1–11.

Article  Google Scholar 

Malmo V, Nes BM, Amundsen BH, Tjonna AE, Stoylen A, Rossvoll O, et al. Aerobic interval training reduces the burden of Atrial fibrillation in the short term: a randomized trial. Circulation. 2016;133(5):466–73.

Article  PubMed  Google Scholar 

Osbak PS, Mourier M, Kjaer A, Henriksen JH, Kofoed KF, Jensen GB. A randomized study of the effects of exercise training on patients with atrial fibrillation. Am Heart J. 2011;162(6):1080–7.

Article  PubMed  Google Scholar 

Ades PA, Savage PD. The treatment of obesity in cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2021;41(5):295–301.

Article  PubMed  PubMed Central  Google Scholar 

Ades PA, Savage PD. Obesity in coronary heart disease: an unaddressed behavioral risk factor. Vol. 104, Preventive Medicine. Academic Press Inc.; 2017. p. 117–9. Available from: https://pubmed.ncbi.nlm.nih.gov/28414064/. [cited 2020 Sep 20].

Wharton S, Lau DCW, Vallis M, Sharma AM, Biertho L, Campbell-Scherer D, et al. Obesity in adults: a clinical practice guideline. CMAJ. 2020;192(31):E875–91.

Article  PubMed  PubMed Central  Google Scholar 

Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004;31(2):143–64.

Article  PubMed  Google Scholar 

Ntoumanis N, Ng JYY, Prestwich A, Quested E, Hancox JE, Thøgersen-Ntoumani C, et al. A meta-analysis of self-determination theory-informed intervention studies in the health domain: effects on motivation, health behavior, physical, and psychological health. Health Psychol Rev. 2020; Available from: https://www.tandfonline.com/doi/abs/https://doi.org/10.1080/17437199.2020.1718529. [cited 2020 Oct 16].

Lutes LD, Winett RA, Barger SD, Wojcik JR, Herbert WG, Nickols-Richardson SM, et al. Small changes in nutrition and physical activity promote weight loss and maintenance: 3-month evidence from the ASPIRE randomized trial. Annals of Behavioral Medicine. 2008 Jun 21;35(3):351–7. Available from: https://academic.oup.com/abm/article/35/3/351-357/4561496. [cited 2018 Nov 22].

Lutes LD, DiNatale E, Goodrich DE, Ronis DL, Gillon L, Kirsh S, et al. A randomized trial of a small changes approach for weight loss in veterans: design, rationale, and baseline characteristics of the ASPIRE-VA trial. Contemp Clin Trials. 2013 Jan;34(1):161–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23041618. [cited 2018 Nov 22].

Lutes LD, Daiss SR, Barger SD, Read M, Steinbaugh E, Winett RA. Small changes approach promotes initial and continued weight loss with a phone-based followup: nine-month outcomes from ASPIRES II. American Journal of Health Promotion. 2012 Mar;26(4):235–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22375574. [cited 2018 Nov 13].

Damschroder LJ, Lutes LD, Kirsh S, Kim HM, Gillon L, Holleman RG, et al. Small-changes obesity treatment among veterans: 12-month outcomes. Am J Prev Med. 2014;47(5):541–53. Available from: https://doi.org/10.1016/j.amepre.2014.06.016. [cited 2018 Nov 2].

Lutes LD, Damschroder LJ, Masheb R, Kim HM, Gillon L, Holleman RG, et al. Behavioral treatment for Veterans with obesity: 24-month weight outcomes from the ASPIRE-VA Small Changes randomized trial. J Gen Intern Med. 2017 Apr 7;32(S1):40–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28271430. [cited 2018 Nov 22].

Ciszewski S, Lutes LD, Walsh Z, Tate D. Small-Change behavioural intervention approaches to weight loss: a systematic review. Ann Behav Med. 2018;52:S577.

Google Scholar 

Larky DA, Bagheri R, Abbasnezhad A, Tinsley GM, Alipour M, Wong A. Effects of gradual weight loss vs rapid weight loss on body composition and resting metabolic rate: a systematic review and meta-analysis. British Journal of Nutrition. Cambridge University Press; 2020. p. 1–12. Available from: /core/journals/british-journal-of-nutrition/article/effects-of-gradual-weight-loss-v-rapid-weight-loss-on-body-composition-and-rmr-a-systematic-review-and-metaanalysis/427E2A512D278FC053CEBB73995FEEFC. [cited 2020 Oct 1].

Bates RW, Bailey C, Topping AE. € Out of sync’: a qualitative investigation of patients’ experiences of atrial fibrillation and perceptions of weight management. BMJ Open. 2022 Nov 7;12(11).

Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, SPIRIT, et al. explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;2013:346.

Google Scholar 

Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. Pilot Feasibility Stud. 2016;2(64).

Martin BJ, Hauer T, Arena R, Austford LD, Galbraith PD, Lewin AM, et al. Cardiac rehabilitation attendance and outcomes in coronary artery disease patients. Circulation. 2012 Aug 7;126(6):677–87. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22777176. [cited 2017 Jul 31].

Armstrong MJ, Sigal RJ, Arena R, Hauer TL, Austford LD, Aggarwal S, et al. Cardiac rehabilitation completion is associated with reduced mortality in patients with diabetes and coronary artery disease. Diabetologia. 2015 Mar 6;58(4):691–8. Available from: www.icd9data.com/2007/Volume1. [cited 2020 Oct 7].

Thompson S, Wiebe N, Arena R, Rouleau C, Aggarwal S, Wilton SB, et al. Effectiveness and utilization of cardiac rehabilitation among people with CKD. Kidney Int Rep. 2021;6(6):1537–47.

Article  PubMed  PubMed Central  Google Scholar 

Liu H, Southern DA, Arena R, Sajobi T, Aggarwal S, James MT, et al. Cardiac rehabilitation and risk of incident atrial fibrillation in patients with coronary artery disease. Can J Cardiol. 2022 Oct 1;38(10):1621–8. Available from: https://pubmed.ncbi.nlm.nih.gov/35691566/. [cited 2023 Dec 5].

Williamson T, Moran C, Chirico D, Arena R, Ozemek C, Aggarwal S, et al. Cancer and cardiovascular disease: the impact of cardiac rehabilitation and cardiorespiratory fitness on survival. Int J Cardiol. 2021;15(343):139–45.

Article  Google Scholar 

Armstrong MJ, Mottershead TA, Ronksley PE, Sigal RJ, Campbell TS, Hemmelgarn BR. Motivational interviewing to improve weight loss in overweight and/or obese patients: a systematic review and meta-analysis of randomized controlled trials. Obesity Reviews. 2011 Jul 1;12(9):709–23. Available from: http://doi.wiley.com/https://doi.org/10.1111/j.1467-789X.2011.00892.x. [cited 2017 Jun 29].

Miller WR, Rollnick S. Motivational interviewing, preparing people to change addictive behavior. New York: The Guilford Press; 1991.

Google Scholar 

Middeldorp ME, Pathak RK, Meredith M, Mehta AB, Elliott AD, Mahajan R, et al. PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study. EP Europace. 2018 Jun 14; Available from: http://www.ncbi.nlm.nih.gov/pubmed/29912366. [cited 2018 Nov 13].

KardiaMobile. 2020. Available from: https://www.alivecor.com/kardiamobile

Wegner FK, Kochhäuser S, Ellermann C, Lange PS, Frommeyer G, Leitz P, et al. Prospective blinded Evaluation of the smartphone-based AliveCor Kardia ECG monitor for Atrial Fibrillation detection: the PEAK-AF study. Eur J Intern Med. 2020 Mar 1;73:72–5. Available from: https://pubmed.ncbi.nlm.nih.gov/31806411/. [cited 2020 Sep 20]

William AD, Kanbour M, Callahan T, Bhargava M, Varma N, Rickard J, et al. Assessing the accuracy of an automated atrial fibrillation detection algorithm using smartphone technology: The iREAD Study. Heart Rhythm. 2018 Oct 1;15(10):1561–5. Available from: http://www.heartrhythmjournal.com/article/S1547527118306611/fulltext. [cited 2020 Oct 6].

Brasier N, Raichle CJ, Dörr M, Becke A, Nohturfft V, Weber S, et al. Detection of atrial fibrillation with a smartphone camera: first prospective, international, two-centre, clinical validation study (DETECT AF PRO). Europace. 2019 Jan 1;21(1):41–7. Available from: https://clinicaltrials.gov/ct2/show/NCT02949180. [cited 2020 Oct 6].

Parker K, Stone JA, Arena R, Lundberg D, Aggarwal S, Goodhart D, et al. An early cardiac access clinic significantly improves cardiac rehabilitation participation and completion rates in low-risk ST-elevation myocardial infarction patients. Can J Cardiol. 2011;27(5):619–27.

Article 

留言 (0)

沒有登入
gif